ImmunoTargets and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.1 | Q2 | 62.3% | 1.110 | Q2 | 86.5% |
| 2024 | 4.4 | Q2 | 69.6% | 2.291 | Q1 | 96.4% |
| 2023 | 6.2 | Q1 | 80.6% | 2.140 | Q1 | 96.1% |
| 2022 | 7.2 | 79.2% | 1.681 | Q1 | 94.3% | |
| 2021 | — | 14.6% | — | 5.2% | ||
| 2020 | — | — | 0.256 | Q4 | 45.0% | |
| 2019 | — | — | 1.703 | Q1 | 94.1% | |
| 2018 | — | — | 2.355 | Q1 | 96.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2253-1556
country
NZcoverage
2015-2026